T1	Or 29 31	or
E1	Or:T1 Arg:T30 Arg2:T31
T3	Age 63 67	aged
E3	Age:T3 Eq-Comparison:E4
T4	Eq-Comparison 68 79	18 or older
E4	Eq-Comparison:T4 Value:T32 Operator:T33
T5	Negation 85 87	No
E5	Negation:T5 Negates:E6
T6	Assertion 88 96	symptoms
E6	Assertion:T6 Asserted:E7 Asserted2:E10
A1	Assertion-Type-Value E6 possible
T7	Condition 100 103	ALS
E7	Condition:T7 Name:T34
T8	Or 104 106	or
E8	Or:T8 Arg:E7 Arg2:E10
T9	Modifier 107 122	fronto-temporal
E9	Modifier:T9 Modifies:T36
T10	Condition 123 131	dementia
E10	Condition:T10 Name:T36
T11	Temporal-Connection 132 134	at
E11	Temporal-Connection:T11 Arg:E10 Arg2:E12
A2	Temporal-Connection-Type-Value E11 during
T12	Study 135 145	enrollment
E12	Study:T12 
T14	Condition 191 194	ALS
E14	Condition:T14 Name:T37
T15	Condition 231 257	ALS-spectrum gene mutation
E15	Condition:T15 Name:T38
T16	Or 259 261	or
E16	Or:T16 Arg:E15 Arg2:E17
T17	Procedure 279 294	genetic testing
E17	Procedure:T17 Name:T40 Temporality:E30
T18	And 295 298	and
E18	And:T18 Arg:E17 Arg2:E19
T20	Condition 327 353	ALS-spectrum gene mutation
E20	Condition:T20 Name:T44
T21	Assertion 360 370	Willing to
E21	Assertion:T21 Asserted:E22
A3	Assertion-Type-Value E21 hypothetical
T22	Procedure 379 394	genetic testing
E22	Procedure:T22 Name:T45
T24	Assertion 447 457	Willing to
E24	Assertion:T24 Asserted:T23
A5	Assertion-Type-Value E24 hypothetical
T25	Eq-Comparison 518 535	every 6-24 months
E25	Eq-Comparison:T25 Value:T46 Operator:T47 Value:T48 Temporal-Unit:T49
T26	Study 540 545	study
E26	Study:T26 
T27	Condition 746 749	HIV
E27	Condition:T27 Name:T50
T28	Condition 761 772	hepatitis B
E28	Condition:T28 Name:T51
T29	Condition 784 795	hepatitis C
E29	Condition:T29 Name:T52
T30	Life-Stage-And-Gender 25 28	Men
A6	Life-Stage-And-Gender-Type T30 male
T31	Life-Stage-And-Gender 32 37	women
A7	Life-Stage-And-Gender-Type T31 female
T32	Eq-Value 68 70	18
T33	Eq-Operator 71 79	or older
A8	Eq-Operator-Value T33 GTEQ
T34	Condition-Name 100 103	ALS
T36	Condition-Name 123 131	dementia
T37	Condition-Name 191 194	ALS
T38	Condition-Name 231 257	ALS-spectrum gene mutation
T40	Procedure-Name 279 294	genetic testing
T42	Polarity 311 319	positive
A11	Polarity-Value T42 positive
T44	Condition-Name 327 353	ALS-spectrum gene mutation
T45	Procedure-Name 379 394	genetic testing
T46	Eq-Value 524 525	6
T47	Eq-Operator 525 526	-
A12	Eq-Operator-Value T47 BETWEEN
T48	Eq-Value 526 528	24
T49	Eq-Temporal-Unit 529 535	months
A13	Eq-Temporal-Unit-Value T49 month
T50	Condition-Name 746 749	HIV
T51	Condition-Name 761 772	hepatitis B
T52	Condition-Name 784 795	hepatitis C
T2	Family-Member 158 179	first degree relative
E2	Family-Member:T2 Has:E14
T13	And 214 218	with
E13	And:T13 Arg:E14 Arg2:E15
T35	Eq-Comparison 262 269	already
E30	Eq-Comparison:T35 Temporal-Period:T39
T39	Eq-Temporal-Period 262 269	already
A9	Eq-Temporal-Period-Value T39 past
T19	Observation 304 310	tested
E19	Observation:T19 Name:T41 Polarity:T42
T41	Observation-Name 304 310	tested
A10	Observation-Type-Value T41 lab
R1	Found-By Arg1:E20 Arg2:E19	
T23	Location 468 509	Columbia University Irving Medical Center
A4	Location-Value T23 hospital
T43	Location 511 516	CUIMC
A14	Location-Value T43 hospital
R2	Abbrev-Of Arg1:T43 Arg2:T23	
